首页 正文

Inhibition of GTPase KRASG12D: a review of patent literature

{{output}}
Introduction: KRAS is a critical oncogenic protein intricately involved in tumor progression, and the difficulty in targeting KRAS has led it to be classified as an 'undruggable target.' Among the various KRAS mutations, KRASG12D... ...